May 8 (Reuters) - The U.S Food and Drug Administration on Wednesday recommended healthcare facilities transition away from using Getinge's heart devices as they continued to have safety and quality concerns. (Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh Kuber)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
184.4 SEK | -2.25% | -1.89% | -17.79% |
May. 15 | Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders | DJ |
May. 15 | Getinge Shares Sink After It Limits Sales of Heart Devices | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.79% | 4.88B | |
-24.88% | 7.32B | |
+7.04% | 6.66B | |
+15.10% | 5.5B | |
+14.96% | 4.1B | |
-20.83% | 3.89B | |
-25.03% | 2.83B | |
+44.01% | 2.31B | |
+1.73% | 2.07B | |
+9.75% | 1.97B |
- Stock Market
- Equities
- GETI B Stock
- News Getinge AB
- US FDA recommends healthcare providers switch from Getinge's heart devices